Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-23-025294

Chief Operations Officer sold 520,000 shares at $1.14 ($590,200)

From the SEC's structured data for this filing

Trades in this filing

Dagnon Terry · Chief Operations Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-20 Sale : show line 1 in the form −520,000 $1.14 $590,200 653,058 D
Open-market sales · 520,000 sh · avg $1.14 · $590,200
Loading xslF345X04/doc4.xml…